Wednesday, October 5, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma Merger

WILMINGTON, Del. - Cubist Pharmaceuticals is selling itself too cheaply through an unfair process to Merck, for $102 a share or $8.4 billion, shareholders claim in a class action in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...